Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-3758309 hydrochloride (PF-03758309 hydrochloride) 是一种口服的、可逆的 ATP 竞争性PAK4抑制剂,Kd 为 2.7 nM,Ki 为 18.7 nM。它抑制锚定独立生长、诱导凋亡、细胞骨架重塑和抑制增殖,具有 PAK4 抑制剂的预期细胞功能。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 286 | 现货 | ||
2 mg | ¥ 403 | 现货 | ||
5 mg | ¥ 728 | 现货 | ||
10 mg | ¥ 1,160 | 现货 | ||
25 mg | ¥ 1,850 | 现货 | ||
50 mg | ¥ 3,410 | 现货 | ||
100 mg | ¥ 4,960 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 898 | 现货 |
产品描述 | PF-3758309 hydrochloride (PF-03758309 hydrochloride) , is a PAK4 inhibitor, is also a n orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity. PF-3758309 hydrochloride binds to PAK4, inhibiting PAK4 activity and cancer cell growth. PAK4, a serine/threonine kinase belonging to the p21-activated kinase (PAK) family, is often upregulated in a variety of cancer cell types and plays an important role in cancer cell motility, proliferation, and survival. |
靶点活性 | PAK3:99 nM (IC50), PAK2:190 nM (IC50), PAK1:13.7 nM (Ki), PAK4:18.7 nM (Ki), PAK4:2.7 nM (Kd), PAK6:17.1 nM (Ki), PAK5:18.1 nM (Ki) |
别名 | PF-03758309 hydrochloride |
分子量 | 527.08 |
分子式 | C25H31ClN8OS |
CAS No. | 1279034-84-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (85.37 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.8972 mL | 9.4862 mL | 18.9725 mL | 47.4311 mL |
5 mM | 0.3794 mL | 1.8972 mL | 3.7945 mL | 9.4862 mL | |
10 mM | 0.1897 mL | 0.9486 mL | 1.8972 mL | 4.7431 mL | |
20 mM | 0.0949 mL | 0.4743 mL | 0.9486 mL | 2.3716 mL | |
50 mM | 0.0379 mL | 0.1897 mL | 0.3794 mL | 0.9486 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
PF-3758309 hydrochloride 1279034-84-2 Apoptosis Cytoskeletal Signaling PAK growth PF3758309 hydrochloride PF 3758309 Hydrochloride p21 activated kinases proliferation survival PF-3758309 Hydrochloride PF-03758309 hydrochloride signaling PF 03758309 ATP-competitive PF 3758309 hydrochloride oncogenic PF03758309 Hydrochloride PF3758309 PF-03758309 PF03758309 PF 3758309 PF-03758309 Hydrochloride inhibit tumor PF3758309 Hydrochloride PF-3758309 PF 03758309 Hydrochloride Inhibitor inhibitor